γ-Oryzanol suppresses COX-2 expression by inhibiting reactive oxygen species-mediated Erk1/2 and Egr-1 signaling in LPS-stimulated RAW264.7 macrophages

Biochem Biophys Res Commun. 2017 Sep 16;491(2):486-492. doi: 10.1016/j.bbrc.2017.07.016. Epub 2017 Jul 18.

Abstract

Cyclooxygenase (COX)-2 produces prostanoids, which contribute to inflammatory responses. Nuclear factor (NF)-κB is a key transcription factor mediating COX-2 expression. γ-Oryzanol is an active component in rice bran oil, which inhibits lipopolysaccharide (LPS)-mediated COX-2 expression by inhibiting NF-κB. However, the inhibition of COX-2 expression by γ-oryzanol independently of NF-κB is poorly understood. We found that LPS upregulated Egr-1 expression at the transcriptional level. Forced expression of Egr-1 trans-activated the Cox-2 promoter independently of NF-κB. In contrast, silencing of Egr-1 abrogated LPS-mediated COX-2 expression. LPS produced reactive oxygen species (ROS), which, in turn, induced Egr-1 expression via the Erk1/2 MAPK pathway. ROS scavenging activity of γ-oryzanol suppressed Egr-1 expression by inhibiting the Erk1/2 MAPK pathway. Our results suggest that γ-oryzanol inhibits LPS-mediated COX-2 expression by suppressing Erk1/2-mediated Egr-1 expression. This study supports that γ-oryzanol may be useful for ameliorating LPS-mediated inflammatory responses.

Keywords: Cyclooxygenase-2; Egr-1; Erk1/2; Lipopolysaccharide; RAW264.7 macrophages; γ-Oryzanol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antioxidants / pharmacology*
  • Cell Line
  • Cyclooxygenase 2 / genetics*
  • Cyclooxygenase 2 / metabolism
  • Early Growth Response Protein 1 / agonists
  • Early Growth Response Protein 1 / genetics*
  • Early Growth Response Protein 1 / metabolism
  • Gene Expression Regulation
  • Genes, Reporter
  • Lipopolysaccharides / pharmacology
  • Luciferases / genetics
  • Luciferases / metabolism
  • Macrophage Activation
  • Macrophages / cytology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / genetics*
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Phenylpropionates / pharmacology*
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Transcription, Genetic

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Early Growth Response Protein 1
  • Egr1 protein, mouse
  • Lipopolysaccharides
  • NF-kappa B
  • Phenylpropionates
  • Reactive Oxygen Species
  • Luciferases
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Mapk1 protein, mouse
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • gamma-oryzanol